Therapies

Applied Molecular Plots IPO to Back Transport of Biologic Drugs to Gut

11 days ago   |   By Xconomy

The human gut hosts a hub of activity spanning the immune system, the nervous system, and more. But drugging this nexus comes with challenges. Applied Molecular Transport is developing biologic drugs that use a cell's own mechanisms to get a therapy to a target and the biotech is now planning to tap the public markets to finance more tests of its technology in humans. Applied Molecular set a $100 million goal for its IPO, according to paperwork filed with securities regulators. That figure is expected to change but the South San Francisco-based company needs a capital infusion of some...
Read more ...

 


Search by Tags

   Therapies      Immunity      Drug      Biology      Drugs      Applied      Biologic      Biological      BioTech      Biotech      National blog main      San Francisco      San Francisco blog main      San Francisco top stories      Applied Molecular Transport      Biologic Drugs      Clinical trials      Crohn's Disease      Epic Capital Group      FDA      Founders Fund      Inflammation      Inflammatory disorders      Interleukin-10      Investing      IPO      Life Sciences      Randall Mrsny      Tahir Mahmood      Ulcerative colitis  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

104714 Patient Navigator - Contract Appointment

MEDICINE/Infectious Diseases Salary commensurate with qualifications and experienceFiling Deadline: Mon 6/15/2020... Read more ...

Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost

Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost badams Mon, 06/01/2020 - 07:56 Read more ...

AbbVie pens cancer pact with U.S.-China biotech Jacobio

AbbVie pens cancer pact with U.S.-China biotech Jacobio badams Mon, 06/01/2020 - 07:28 Read more ...

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the...

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action badams Mon, 06/01/2020 - 06:40 Read more ...

How a new biotech rule will foster distrust with the public and impede...

In May, federal regulators finalized a new biotechnology policy that will bring sweeping changes to the U.S. food system. Dubbed "SECURE," the rule revises U.S. Department of... Read more ...

FloChiP, a new tool optimizing gene-regulation studies

In the cell, proteins often interact directly with DNA to regulate and influence the expression of genes. For this to happen, proteins need to travel into the cell's nucleus... Read more ...

Researchers control cattle microbiomes to reduce methane and greenhouse gases

Ben-Gurion University of the Negev researchers have learned to control the microbiome of cattle for the first time which could inhibit their methane production, and therefore... Read more ...

Researchers develop biotechnological process for jasmonic acid production

Plants produce the hormone jasmonic acid as a defense response when challenged, making their leaves taste bad to predators. Biologists want to determine whether biological... Read more ...

Gossamer Bio Announces Participation in Upcoming Investor Conferences

SAN DIEGO--- $GOSS-Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease... Read more ...

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of...

SAN DIEGO, June 1, 2020 /PRNewswire/ - DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today... Read more ...